Navigation Links
Avion Pharmaceuticals, LLC., announces further expansion of their Women's Health Sales Team
Date:4/16/2013

ATLANTA, April 16, 2013 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the addition of 45 sales representatives to support their Women's Health Care and Dermatology portfolio of products.  The new sales team has joined the existing 40 representatives in promoting the Prenate® prenatal vitamin family of products along with Nicomide® for inflammatory acne.  In addition, the expanded Avion sales team of 85 representatives will be focused on the launch of FeRiva™ a new prescription iron supplement.  FeRiva delivers two forms of iron utilizing a patented INNER CAP multi-compartment capsule technology.  FeRiva contains 75 mg of elemental iron that includes Ferrochel® (Ferrous Bis-glycinate Sulfate and Ferronyl® (Carbonyl Iron), two preferred forms of iron for improved tolerability and compliance.

"The expansion of our sales team provides the critical level of sales support needed to effectively promote our portfolio of products to our prescriber community.  Avion is well-positioned for continued growth by providing a suite of products that will meet patient needs and our team of sales professionals is poised for success," stated Mike Sullivan , Vice President, Sales and Marketing for Avion Pharmaceuticals. 

"Avion Pharmaceuticals is excited to continue our focused efforts on nurturing the health and nutritional needs of women.  Our sales force expansion is being executed at the optimal juncture in our corporate history to support the progress we have planned for continued growth," added Mark Pugh , CEO for Avion Pharmaceuticals.

About Avion Pharmaceuticals, LLC.
Avion Pharmaceuticals, LLC. is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.

Ferronyl is a registered trademark of ISP Investments, Inc. PureWay-C is a registered trademark of Innovation Laboratories, Inc. Ferrochel is a registered trademark of Albion Laboratories, Inc. covered by U.S. Patents 6,716,814 & 7,838,042.
Covered by one or more claims of U.S. Patent # 7,670,612 (INNERCAP Technologies, Inc).

FeRiva™ is a trademark of Avion Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.

 


'/>"/>
SOURCE Avion Pharmaceuticals, LLC.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Avion Pharmaceuticals, LLC., Launches Prenate Mini
2. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
3. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
4. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
5. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
7. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
8. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
10. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
11. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):